Rob Duncombe, director of pharmacy at The Christie and chair of the Cancer Vanguard’s medicines optimisation group, has contributed to an article in Pharmaceutical Market Europe.

He discussed how the Vanguard’s innovative approach to partnering with industry can contribute to improvements in patient care.

Read the article here.